ro 31-8220 has been researched along with Alloxan Diabetes in 2 studies
Ro 31-8220: a protein kinase C inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazarolli, LH | 1 |
| Folador, P | 1 |
| Moresco, HH | 1 |
| Brighente, IM | 1 |
| Pizzolatti, MG | 1 |
| Silva, FR | 1 |
| Eggen, BJ | 1 |
| Eichberg, J | 1 |
2 other studies available for ro 31-8220 and Alloxan Diabetes
| Article | Year |
|---|---|
Mechanism of action of the stimulatory effect of apigenin-6-C-(2''-O-alpha-l-rhamnopyranosyl)-beta-L-fucopyranoside on 14C-glucose uptake.
Topics: Alloxan; Androstadienes; Animals; Biological Transport; Blood Glucose; Carbon Radioisotopes; Colchic | 2009 |
Phorbol ester-mediated stimulation of phospholipase D activity in sciatic nerve from normal and diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glycerophospholipids; In | 1992 |